Increased Survival Time of a Patient with Metastatic Malignant Melanoma Following Immunotherapy:A Ca

• 作 者: 张勇;宋永平;高全立;
• 机 构: 郑州大学附属肿瘤医院
• 出 处: 第九届中国肿瘤内科大会、第四届中国肿瘤医师大会暨中国抗癌协会肿瘤临床化疗专业委员会2015年学术年会
• 发表日期: 2015年期

　　Metastatic malignant melanoma is limited to the treatment of chemotherapy and radiotherapy.Nowadays, many studies have confirmed that Cytokine-induced killer cells (CIK cells) are heterogeneous cell populations that express CD3 and CD56 as well as the activation receptor of NK ceils (NKG2D), antigen.